Literature DB >> 6994481

Mycobacterium xenopi and pulmonary disease.

J H Koizumi, H M Sommers.   

Abstract

Mycobacterium xenopi was cultured from a portion of surgically resected lung of an asymptomatic patient who had a renal transplant. The patient was receiving azathioprine and prednisone for the prevention of transplant rejection, as well as treatment for previously diagnosed pulmonary tuberculosis. M. xenopi infection was recognized as a second mycobacterial infection. The role of M. xenopi as an opportunistic pathogen in the compromised host is emphasized.

Entities:  

Mesh:

Year:  1980        PMID: 6994481     DOI: 10.1093/ajcp/73.6.826

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  7 in total

Review 1.  Treatment of pulmonary disease caused by opportunist mycobacteria.

Authors:  J Banks
Journal:  Thorax       Date:  1989-06       Impact factor: 9.139

Review 2.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

Review 3.  Epidemiology of infection by nontuberculous mycobacteria.

Authors:  J O Falkinham
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

4.  Update on nontuberculous mycobacterial infections in solid organ and hematopoietic stem cell transplant recipients.

Authors:  B M Knoll
Journal:  Curr Infect Dis Rep       Date:  2014-09       Impact factor: 3.725

5.  Pulmonary infection with mycobacterium xenopi: review of treatment and response.

Authors:  J Banks; A M Hunter; I A Campbell; P A Jenkins; A P Smith
Journal:  Thorax       Date:  1984-05       Impact factor: 9.139

Review 6.  Non-tuberculous mycobacterial infections in solid organ transplant recipients: An update.

Authors:  Cybele L Abad; Raymund R Razonable
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2016-04-27

7.  Mycobacterium xenopi: Evidence for Increased Rate of Clinical Isolation.

Authors:  Martin H Bluth; Ramon Vera; Jafar Razeq; Martin Kramer; Khaled I Abu-Lawi
Journal:  Int J Biomed Sci       Date:  2009-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.